<DOC>
	<DOCNO>NCT02955498</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic characteristic olmesartan S-amlodipine single oral administration Sevikar tab . 10/40mg , combination formulation olmesartan amlodipine reference drug Lodivikar tab . 5/40mg , combination formulation olmesartan S-amlodipine test drug healthy male adult . Additionally safety tolerability two drug evaluate .</brief_summary>
	<brief_title>Clinical Trial Assess Pharmacokinetic Characteristics Lodivikar Tab . 5/40 mg Healthy Adult Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male age 2045 Body weight ≥ 55kg , IBW ± 20 % Subject sign inform consent form willingly Subject serious active cardiovascular , respiratory , hepatologic , renal , hematologic , gastrointestinal , immunologic , dermal , neurologic , psychological disease history disease Subject know hypersensitivity reaction Samlodipine , amlodipine olmesartan dihydropyridine derivative Clinically significant hypotension ( SBP≤100mmHg , DBP≤60mmHg ) hypertension ( SBP≥150mmHg , DBP≥95mmHg ) screen period Subject know history disease gastric surgery affect absorption , Subject follow condition laboratory test AST ALT &gt; UNL ( upper normal limit ) x 1.5 Total bilirubin &gt; UNL x 1.5 Renal failure CLcr &lt; 50mL/min calculated CockcroftGault [ CockcroftGault GFR = ( 140age ) * ( Wt kg ) / ( 72 *Cr ) ] Serum potassium &lt; 3.5 mEq/L &gt; 5.5 mEq/L Continued excessive use caffeine ( caffeine &gt; five cups/day ) , alcohol ( alcohol &gt; 30g/day ) severe heavy smoker ( cigarette &gt; 10 cigarette per day ) Participation clinical investigation within 60days prior study medication dose Subject whole blood donation within 60days , component blood donation within 30days prior study medication dose Subject take inducer inhibitor drug metabolism enzyme barbital within 28days prior study medication dose Use prescription medication include oriental medication within 14 day prior study medication dose overthecounter medication within 7 day prior study medication dose Subject mental illness drug addiction Subject take food affect absorption , distribution , metabolism excretion drug within 7days prior study medication dose Subject decision nonparticipation investigator 's review due laboratory test result excuse nonresponding request instruction investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>